Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QFB6
Term | Name | Level | Count |
---|---|---|---|
GO:0006450 | regulation of translational fidelity | 3 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0065008 | regulation of biological quality | 2 | 2 |
GO:0006082 | organic acid metabolic process | 3 | 4 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 4 |
GO:0006399 | tRNA metabolic process | 7 | 4 |
GO:0006520 | amino acid metabolic process | 3 | 4 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 4 |
GO:0006807 | nitrogen compound metabolic process | 2 | 4 |
GO:0008152 | metabolic process | 1 | 4 |
GO:0009987 | cellular process | 1 | 4 |
GO:0016070 | RNA metabolic process | 5 | 4 |
GO:0019752 | carboxylic acid metabolic process | 5 | 4 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 4 |
GO:0034660 | ncRNA metabolic process | 6 | 4 |
GO:0043038 | amino acid activation | 4 | 4 |
GO:0043039 | tRNA aminoacylation | 5 | 4 |
GO:0043170 | macromolecule metabolic process | 3 | 4 |
GO:0043436 | oxoacid metabolic process | 4 | 4 |
GO:0044237 | cellular metabolic process | 2 | 4 |
GO:0044238 | primary metabolic process | 2 | 4 |
GO:0044281 | small molecule metabolic process | 2 | 4 |
GO:0046483 | heterocycle metabolic process | 3 | 4 |
GO:0071704 | organic substance metabolic process | 2 | 4 |
GO:0090304 | nucleic acid metabolic process | 4 | 4 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 4 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 4 |
GO:0006418 | tRNA aminoacylation for protein translation | 6 | 3 |
GO:0006419 | alanyl-tRNA aminoacylation | 7 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 11 |
GO:0002161 | aminoacyl-tRNA editing activity | 5 | 2 |
GO:0002196 | Ser-tRNA(Ala) hydrolase activity | 6 | 2 |
GO:0003824 | catalytic activity | 1 | 6 |
GO:0005488 | binding | 1 | 11 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0036094 | small molecule binding | 2 | 11 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 6 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 6 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 6 |
GO:1901265 | nucleoside phosphate binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0004812 | aminoacyl-tRNA ligase activity | 4 | 4 |
GO:0005524 | ATP binding | 5 | 4 |
GO:0016874 | ligase activity | 2 | 4 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3 | 4 |
GO:0017076 | purine nucleotide binding | 4 | 4 |
GO:0030554 | adenyl nucleotide binding | 5 | 4 |
GO:0032553 | ribonucleotide binding | 3 | 4 |
GO:0032555 | purine ribonucleotide binding | 4 | 4 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 4 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 4 |
GO:0043167 | ion binding | 2 | 4 |
GO:0043168 | anion binding | 3 | 4 |
GO:0097367 | carbohydrate derivative binding | 2 | 4 |
GO:0004813 | alanine-tRNA ligase activity | 5 | 3 |
GO:0003676 | nucleic acid binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 270 | 274 | PF00656 | 0.412 |
CLV_MEL_PAP_1 | 4 | 10 | PF00089 | 0.412 |
CLV_NRD_NRD_1 | 103 | 105 | PF00675 | 0.377 |
CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.370 |
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.380 |
CLV_NRD_NRD_1 | 235 | 237 | PF00675 | 0.547 |
CLV_NRD_NRD_1 | 345 | 347 | PF00675 | 0.393 |
CLV_NRD_NRD_1 | 389 | 391 | PF00675 | 0.372 |
CLV_NRD_NRD_1 | 411 | 413 | PF00675 | 0.468 |
CLV_PCSK_KEX2_1 | 103 | 105 | PF00082 | 0.377 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.370 |
CLV_PCSK_KEX2_1 | 235 | 237 | PF00082 | 0.557 |
CLV_PCSK_KEX2_1 | 345 | 347 | PF00082 | 0.435 |
CLV_PCSK_KEX2_1 | 358 | 360 | PF00082 | 0.359 |
CLV_PCSK_KEX2_1 | 389 | 391 | PF00082 | 0.372 |
CLV_PCSK_KEX2_1 | 411 | 413 | PF00082 | 0.468 |
CLV_PCSK_PC1ET2_1 | 358 | 360 | PF00082 | 0.439 |
CLV_PCSK_PC7_1 | 231 | 237 | PF00082 | 0.474 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.400 |
CLV_PCSK_SKI1_1 | 348 | 352 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 355 | 359 | PF00082 | 0.387 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.636 |
CLV_PCSK_SKI1_1 | 412 | 416 | PF00082 | 0.385 |
DEG_SPOP_SBC_1 | 213 | 217 | PF00917 | 0.408 |
DOC_CYCLIN_yCln2_LP_2 | 111 | 117 | PF00134 | 0.470 |
DOC_CYCLIN_yCln2_LP_2 | 164 | 170 | PF00134 | 0.400 |
DOC_MAPK_gen_1 | 151 | 157 | PF00069 | 0.328 |
DOC_MAPK_gen_1 | 355 | 364 | PF00069 | 0.404 |
DOC_MAPK_gen_1 | 389 | 397 | PF00069 | 0.430 |
DOC_MAPK_MEF2A_6 | 299 | 307 | PF00069 | 0.344 |
DOC_MAPK_MEF2A_6 | 389 | 397 | PF00069 | 0.470 |
DOC_PP1_RVXF_1 | 302 | 308 | PF00149 | 0.325 |
DOC_PP1_RVXF_1 | 468 | 474 | PF00149 | 0.528 |
DOC_PP2B_LxvP_1 | 155 | 158 | PF13499 | 0.487 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.382 |
DOC_USP7_MATH_1 | 240 | 244 | PF00917 | 0.634 |
DOC_USP7_MATH_1 | 250 | 254 | PF00917 | 0.491 |
DOC_USP7_MATH_1 | 271 | 275 | PF00917 | 0.494 |
DOC_USP7_MATH_1 | 85 | 89 | PF00917 | 0.573 |
DOC_USP7_UBL2_3 | 476 | 480 | PF12436 | 0.436 |
DOC_WW_Pin1_4 | 110 | 115 | PF00397 | 0.424 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.466 |
DOC_WW_Pin1_4 | 443 | 448 | PF00397 | 0.526 |
LIG_14-3-3_CanoR_1 | 265 | 270 | PF00244 | 0.416 |
LIG_14-3-3_CanoR_1 | 359 | 363 | PF00244 | 0.442 |
LIG_14-3-3_CanoR_1 | 423 | 429 | PF00244 | 0.581 |
LIG_Actin_WH2_2 | 398 | 413 | PF00022 | 0.466 |
LIG_BRCT_BRCA1_1 | 58 | 62 | PF00533 | 0.340 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.393 |
LIG_FHA_1 | 144 | 150 | PF00498 | 0.410 |
LIG_FHA_1 | 152 | 158 | PF00498 | 0.373 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.392 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.419 |
LIG_FHA_1 | 359 | 365 | PF00498 | 0.388 |
LIG_FHA_1 | 381 | 387 | PF00498 | 0.517 |
LIG_FHA_1 | 466 | 472 | PF00498 | 0.521 |
LIG_FHA_1 | 72 | 78 | PF00498 | 0.485 |
LIG_FHA_2 | 282 | 288 | PF00498 | 0.424 |
LIG_FHA_2 | 349 | 355 | PF00498 | 0.493 |
LIG_FHA_2 | 440 | 446 | PF00498 | 0.486 |
LIG_LIR_Gen_1 | 165 | 175 | PF02991 | 0.364 |
LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.431 |
LIG_LIR_Gen_1 | 337 | 343 | PF02991 | 0.508 |
LIG_LIR_Gen_1 | 396 | 405 | PF02991 | 0.355 |
LIG_LIR_Gen_1 | 481 | 489 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 49 | 60 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 165 | 171 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 184 | 189 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 2 | 8 | PF02991 | 0.486 |
LIG_LIR_Nem_3 | 337 | 342 | PF02991 | 0.508 |
LIG_LIR_Nem_3 | 396 | 401 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 481 | 485 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 49 | 55 | PF02991 | 0.348 |
LIG_PCNA_yPIPBox_3 | 142 | 156 | PF02747 | 0.402 |
LIG_SH2_CRK | 168 | 172 | PF00017 | 0.455 |
LIG_SH2_CRK | 52 | 56 | PF00017 | 0.418 |
LIG_SH2_STAP1 | 52 | 56 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 168 | 171 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.499 |
LIG_SH2_STAT5 | 292 | 295 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 306 | 309 | PF00017 | 0.217 |
LIG_SH3_3 | 124 | 130 | PF00018 | 0.415 |
LIG_SH3_3 | 179 | 185 | PF00018 | 0.491 |
LIG_SH3_3 | 257 | 263 | PF00018 | 0.462 |
LIG_SH3_3 | 381 | 387 | PF00018 | 0.515 |
LIG_SH3_3 | 57 | 63 | PF00018 | 0.322 |
LIG_SUMO_SIM_anti_2 | 337 | 344 | PF11976 | 0.511 |
LIG_SUMO_SIM_par_1 | 265 | 270 | PF11976 | 0.334 |
LIG_SUMO_SIM_par_1 | 360 | 366 | PF11976 | 0.465 |
LIG_SUMO_SIM_par_1 | 412 | 417 | PF11976 | 0.438 |
LIG_SUMO_SIM_par_1 | 95 | 100 | PF11976 | 0.503 |
LIG_TYR_ITIM | 50 | 55 | PF00017 | 0.448 |
MOD_CK1_1 | 46 | 52 | PF00069 | 0.491 |
MOD_CK2_1 | 281 | 287 | PF00069 | 0.405 |
MOD_CK2_1 | 348 | 354 | PF00069 | 0.492 |
MOD_CK2_1 | 439 | 445 | PF00069 | 0.441 |
MOD_CK2_1 | 475 | 481 | PF00069 | 0.483 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.579 |
MOD_GlcNHglycan | 416 | 419 | PF01048 | 0.397 |
MOD_GlcNHglycan | 430 | 433 | PF01048 | 0.475 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.602 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.245 |
MOD_GSK3_1 | 156 | 163 | PF00069 | 0.389 |
MOD_GSK3_1 | 177 | 184 | PF00069 | 0.469 |
MOD_GSK3_1 | 273 | 280 | PF00069 | 0.332 |
MOD_GSK3_1 | 344 | 351 | PF00069 | 0.498 |
MOD_GSK3_1 | 376 | 383 | PF00069 | 0.536 |
MOD_GSK3_1 | 439 | 446 | PF00069 | 0.491 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.638 |
MOD_N-GLC_1 | 46 | 51 | PF02516 | 0.558 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.410 |
MOD_NEK2_1 | 331 | 336 | PF00069 | 0.474 |
MOD_NEK2_1 | 56 | 61 | PF00069 | 0.342 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.476 |
MOD_NEK2_2 | 475 | 480 | PF00069 | 0.479 |
MOD_PKA_1 | 151 | 157 | PF00069 | 0.328 |
MOD_PKA_1 | 194 | 200 | PF00069 | 0.437 |
MOD_PKA_1 | 358 | 364 | PF00069 | 0.494 |
MOD_PKA_2 | 344 | 350 | PF00069 | 0.513 |
MOD_PKA_2 | 358 | 364 | PF00069 | 0.494 |
MOD_PKA_2 | 422 | 428 | PF00069 | 0.570 |
MOD_Plk_1 | 46 | 52 | PF00069 | 0.378 |
MOD_Plk_2-3 | 363 | 369 | PF00069 | 0.435 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.379 |
MOD_Plk_4 | 22 | 28 | PF00069 | 0.406 |
MOD_Plk_4 | 298 | 304 | PF00069 | 0.453 |
MOD_Plk_4 | 338 | 344 | PF00069 | 0.499 |
MOD_Plk_4 | 380 | 386 | PF00069 | 0.567 |
MOD_Plk_4 | 481 | 487 | PF00069 | 0.398 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.342 |
MOD_ProDKin_1 | 110 | 116 | PF00069 | 0.430 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.465 |
MOD_ProDKin_1 | 443 | 449 | PF00069 | 0.523 |
MOD_SUMO_for_1 | 202 | 205 | PF00179 | 0.462 |
TRG_DiLeu_BaEn_1 | 481 | 486 | PF01217 | 0.479 |
TRG_ENDOCYTIC_2 | 168 | 171 | PF00928 | 0.368 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.393 |
TRG_ER_diArg_1 | 102 | 104 | PF00400 | 0.427 |
TRG_ER_diArg_1 | 130 | 132 | PF00400 | 0.388 |
TRG_ER_diArg_1 | 251 | 254 | PF00400 | 0.601 |
TRG_ER_diArg_1 | 388 | 390 | PF00400 | 0.363 |
TRG_ER_diArg_1 | 401 | 404 | PF00400 | 0.353 |
TRG_ER_diArg_1 | 410 | 412 | PF00400 | 0.450 |
TRG_NLS_MonoExtN_4 | 37 | 44 | PF00514 | 0.592 |
TRG_Pf-PMV_PEXEL_1 | 254 | 258 | PF00026 | 0.535 |
TRG_Pf-PMV_PEXEL_1 | 325 | 330 | PF00026 | 0.444 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1V1 | Leptomonas seymouri | 73% | 99% |
A0A0S4J566 | Bodo saltans | 41% | 100% |
A0A1X0NTW0 | Trypanosomatidae | 42% | 100% |
A0A3S7WTE7 | Leishmania donovani | 96% | 100% |
A0A422NRG2 | Trypanosoma rangeli | 44% | 100% |
A4H839 | Leishmania braziliensis | 83% | 99% |
A4HWG6 | Leishmania infantum | 95% | 100% |
C9ZXY1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9AQ67 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
P53960 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 100% |
Q08B09 | Xenopus laevis | 29% | 100% |
Q3THG9 | Mus musculus | 32% | 100% |
Q5XI97 | Rattus norvegicus | 30% | 100% |
Q6DEJ5 | Danio rerio | 30% | 100% |
Q7ZYJ9 | Xenopus laevis | 28% | 100% |
Q9BTE6 | Homo sapiens | 30% | 100% |